XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.58%)
As of: Sep 30, 2026 · 11:41 AM EDT

XORTX Therapeutics (XRTX) Restructuring Costs (2020)

Updated

XORTX Therapeutics (XRTX) recorded Restructuring Costs of $846.00 in the year ended Dec 31, 2020, up 101.4% from $420.00 a year earlier.

Analysis

XORTX Therapeutics (XRTX) Restructuring Costs (2020) Analysis & Trends

  • Per Business Quant data, XRTX's Restructuring Costs was $420.00 in the year ended Dec 31, 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 XORTX Therapeutics 1.62 Mn -1.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 425.00
Mar 31, 2020 421.00
API Access

XORTX Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=XRTX&period=max&api_key=YOUR_API_KEY